Processa Pharmaceuticals and Upcoming Industry Conferences
Processa Pharmaceuticals' Upcoming Engagements
HANOVER, Md. -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) is excited to announce its participation in several significant investor and industry conferences throughout the month of September. These conferences serve as a platform for the management team to engage with investors and industry peers, sharing insights about the company’s innovative approaches to oncology treatment.
Key Conferences in September
Throughout September, Processa Pharmaceuticals will partake in two notable events:
H.C. Wainwright Annual Global Investment Conference
The first event is the H.C. Wainwright 26th Annual Global Investment Conference, taking place from September 9-11, 2024, at the Lotte New York Palace Hotel. During this conference, the management team will conduct one-on-one meetings with investors and deliver a company presentation. For those unable to attend in person, the presentation will be available for on-demand viewing starting September 9, at 7:00 am Eastern time on the Investors section of Processa’s website.
European Society for Medical Oncology (ESMO) Congress 2024
Following the H.C. Wainwright conference, Processa will participate in the European Society for Medical Oncology (ESMO) Congress 2024, scheduled for September 13-17, 2024, in Barcelona. This event will be a key opportunity for the management to connect with clinicians, researchers, and potential partners in the industry, focusing on forging collaborations aimed at improving cancer treatment.
Innovations in Chemotherapy at Processa
Processa Pharmaceuticals is at the forefront of developing Next Generation Chemotherapy (NGC) drugs. These innovative therapies promise enhanced safety and efficacy by modifying existing FDA-approved oncology drugs. The modifications impact the metabolism and distribution of these treatments, while still retaining their essential mechanisms to target and eliminate cancer cells. This strategic approach aims to produce more effective therapies that also offer improved tolerability for patients.
The Path Forward with Regulatory Science
One of the defining aspects of Processa’s strategy is its commitment to a comprehensive Regulatory Science Approach. By effectively integrating regulatory insights with their novel oncology pipeline, the company endeavors to streamline the development of innovative cancer therapies. The goal is to provide patients with effective treatment options that not only target cancer cells but also enhance their quality of life through better tolerability.
Company Contact Information
Company Contact:
Patrick Lin
(925) 683-3218
plin@processapharma.com
Investor Relations Contact:
Yvonne Briggs
LHA Investor Relations
(310) 691-7100
ybriggs@lhai.com
Frequently Asked Questions
What does Processa Pharmaceuticals focus on?
Processa Pharmaceuticals focuses on developing innovative chemotherapy drugs that improve safety and efficacy for cancer treatment.
When are the conferences taking place?
The conferences are being held on September 9-11 and September 13-17, 2024.
Where is the H.C. Wainwright conference held?
The H.C. Wainwright conference will be at the Lotte New York Palace Hotel.
What type of meetings will Processa hold at these conferences?
Management will hold one-on-one meetings with investors and participate in discussions with industry experts and potential partners.
How can I learn more about Processa’s latest developments?
You can visit Processa Pharmaceuticals’ official website for the latest updates and information on their innovative therapies.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- LIFT Expands Cali Property Significantly Through Strategic Staking
- Constellation Brands Adjusts Earnings Outlook for 2025
- Xiaohongshu Street Life Festival Draws Throngs and Creativity
- CaringBridge Welcomes New Board Members and Leadership Roles
- Astronergy Expands Solar Energy Revolution Across Africa
- Florida Crystals® Marks Organic Month with Milestones and New Packaging
- gRNA Market Growth Driven by CRISPR-Cas9 and Innovation
- Growing Demand for Pick to Light Solutions Transforming Industries
- TEN, Ltd. Schedules Q2 2024 Results Event and Conference Call
- Music Licensing, Inc. Expands Portfolio with New Acquisition
- Lerner Publishing Group Expands Portfolio with New Acquisition
- Plastic Caps and Closures Market Set to Reach USD 96.28 Billion
- Understanding Nexans S.A. Share Capital and Voting Rights
- Cyclacel Pharmaceuticals Pursues Hearing After Delisting Notice
- Yukon Metals Unveils Promising Gold and Copper Discovery
- Constellation Brands Revises Fiscal 2025 Financial Outlook
- Coloplast A/S Share Trading Insights for Board and Executives
- Semnur Pharmaceuticals and Denali Capital Announce Merger
- DemandScience Achieves a Historic 11th Inc. 5000 Honor
- Bio-Based Coatings Market Growth Driven by Eco-Friendly Demand
- Optical Modulators Market Growth Metrics and Key Drivers
- ChartPath and WoundZoom Partner to Revolutionize Wound Care
- Global Cash Handling Device Market Growth Insights
- Affiliated Network Providers and Aurora Health Join Forces
- AGBA and Triller Finalize Amended Merger Agreement Details
Recent Articles
- LIFT Expands Cali Property Significantly Through Strategic Staking
- Real Estate Investment Trusts Drive Global Markets Upward
- Cambridge Judge Launches Family Business Leadership Programme
- GSE Worldwide Receives Strategic Investment to Fuel Growth
- John Ballantyne Joins Glucotrack Board to Advance Innovation
- Exploring Stereotaxis Robotic Innovations at HRX Congress
- Lake City Bank Enhances Warsaw Campus with New Center
- VCI Global Secures $18 Million Contract for IPO Listings
- UMMC Partners with Fiducius for Financial Wellness Initiative
- Flipster Launches Earn Campaign for BTC, ETH, and USDT Rewards
- Nokia's Strategic Fibre Network Deal with AT&T
- Investors Weigh AI Boom Amidst Market Volatility
- Orion Energy Systems to Showcase at H.C. Wainwright Event
- ADC Therapeutics Announces Conference Presentations in September
- GH Research Promotes Dr. Velichka Valcheva to CEO Position
- RYVYL Inc. to Present Innovative Solutions at Conference
- Foghorn Therapeutics Welcomes Anna Rivkin as CBO
- Colliers Expands Portfolio with Pritchard Francis Acquisition
- VAPORESSO: Celebrating 9 Years of Innovation and Adventure
- Nathan Gnanasambandam Joins RhythmX AI as VP of AI
- NextEra Energy Announces Investor Meetings for September 2024
- Prime Mining Corp Reports High-Grade Drilling Expansion
- Top Value Stocks for a Stronger Q3 Performance Ahead
- Understanding Net Asset Values for WisdomTree ETFs
- 5G Chipsets Market Growth Projected to Exceed $132 Billion